Claude is a product, not a public company

Claude is the AI assistant built by Anthropic, and it is the product at the center of Alexander Green’s “Secret Backdoor to the REAL #1 Tech IPO of 2026” presentation in The Oxford Communiqué. Green describes Claude as “far and away the best AI on the face of the planet,” and the pitch is built around getting exposure to the company behind it. The first thing to understand is that Claude is not itself a stock. There is no Claude ticker, no Claude IPO, and no way to buy Claude directly. Claude is a product, and the company that owns it is Anthropic, which is still private.

That distinction trips up a lot of investors, because Claude is everywhere now. It powers coding tools, customer service, and a growing share of business workflows, and its name shows up in headlines daily. But when you want to invest in Claude, you are really investing in Anthropic, and that means going through one of the funds that hold Anthropic shares.

VCX: the fund with Claude’s largest shareholder

The most direct route is Fundrise Venture, a closed-end fund that trades under the ticker VCX. It is the Fundrise Innovation Fund, which listed on March 19, 2026 at roughly $19 net asset value, and its top holdings are Anthropic, Databricks, and OpenAI, with Anthropic as the biggest position. Because VCX trades on an exchange, any brokerage account can buy it, and it is the closest thing retail investors have to a Claude stock today.

The catch is the price. VCX’s net asset value is estimated at $25 to $30, but the shares trade around $41, a 30 to 40 percent premium. Earlier this spring the shares touched $200, roughly ten times NAV, before lockup expirations pulled them back. Paying $41 for about $28 of underlying assets is a real cost, and it means your return depends as much on the premium as it does on Claude’s growth. Our Anthropic stock guide runs through the mechanics.

ARKVX: a different route to the same company

The second route is Ark Venture, Cathie Wood’s closed-end interval fund trading under the ticker ARKVX. It holds Anthropic alongside SpaceX, OpenAI, and a broader basket of private technology companies, with Anthropic at roughly 4.3 percent of the fund as its fourth-largest position. Unlike VCX, ARKVX prices at net asset value, so you do not pay a premium to get in.

The friction is structural instead. ARKVX charges a 2.9 percent annual fee, has a $500 minimum, and limits redemptions to 5 percent per quarter, which means you cannot always exit when you want. It is a more honestly priced way to own a piece of Claude, but it bundles that exposure with a lot of other companies and charges for the privilege.

What this means for investors

The bottom line is simple. Claude is real, its growth is real, and Anthropic’s revenue tells the story: from about $1 billion in early 2025 to $11.5 billion in a single quarter, with a $65 billion annualized run-rate by the end of July. But there is no Claude stock, and the two funds that stand in for it each carry a cost that matters. VCX makes you pay a premium, and ARKVX makes you pay fees and accept limits. For the full picture of who actually owns Claude and Anthropic, see our explainer on who owns Claude.

Claude’s business numbers

Claude is more than a consumer chatbot. It powers Anthropic’s enterprise push, and the business results show it. Anthropic’s revenue climbed from about $1 billion in early 2025 to $11.5 billion in a single quarter, and its coding product, Claude Code, grew from roughly $500 million to $2.5 billion in five months. The company now counts more than 300,000 business customers, and revenue per employee runs near $8 million. Claude itself has around 350 million monthly actives, fewer than ChatGPT’s more than one billion weekly users, but the business customers are where the durable economics live.

Anyone hunting for a Claude stock will also run into a few adjacent tickers. SK Telecom, trading as SKM, holds an Anthropic stake bought for about $100 million that may now be worth more than $2 billion. The Destiny Tech100 Fund trades as DXYZ, and the KraneShares Public-Private AI & Technology ETF trades as AGIX with roughly 2 percent in Anthropic. Each is a diluted, indirect route rather than a Claude play, and each carries its own premium, fee, or lockup. The point is that there is no clean Claude stock, only a set of wrappers with different costs.

The decision in one line

Claude is a genuinely impressive product, and Anthropic’s growth is real, but the only way to own it today is through a fund with a cost attached. VCX charges you a premium, ARKVX charges you fees and limits, and the smaller tickers dilute you. Decide which cost you can live with, and size the position accordingly.

Ready to see the research? Click here to access Alexander Green’s report.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.